Concepts (180)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Trypanosoma | 6 | 2023 | 9 | 2.770 |
Why?
|
| RNA Editing | 9 | 2023 | 12 | 2.170 |
Why?
|
| Crystallography, X-Ray | 20 | 2019 | 223 | 1.780 |
Why?
|
| Models, Molecular | 20 | 2020 | 453 | 1.760 |
Why?
|
| RNA, Protozoan | 4 | 2016 | 9 | 1.550 |
Why?
|
| Muramidase | 7 | 2009 | 13 | 1.420 |
Why?
|
| Nucleic Acid Conformation | 9 | 2015 | 90 | 1.330 |
Why?
|
| RNA | 4 | 2023 | 111 | 1.280 |
Why?
|
| Software | 5 | 2019 | 125 | 1.180 |
Why?
|
| Bacteriophage T4 | 6 | 2009 | 7 | 1.010 |
Why?
|
| RNA, Double-Stranded | 2 | 2015 | 15 | 0.930 |
Why?
|
| User-Computer Interface | 2 | 2020 | 52 | 0.830 |
Why?
|
| Proto-Oncogene Proteins c-ret | 6 | 2024 | 20 | 0.800 |
Why?
|
| Molecular Dynamics Simulation | 2 | 2021 | 40 | 0.750 |
Why?
|
| Indolizidines | 1 | 2021 | 1 | 0.740 |
Why?
|
| Receptors, Nicotinic | 1 | 2021 | 10 | 0.740 |
Why?
|
| Drug Discovery | 1 | 2021 | 34 | 0.720 |
Why?
|
| Programming Languages | 1 | 2020 | 6 | 0.700 |
Why?
|
| X-Ray Diffraction | 4 | 2024 | 41 | 0.670 |
Why?
|
| Protein Kinase Inhibitors | 6 | 2024 | 157 | 0.610 |
Why?
|
| Viral Proteins | 2 | 2009 | 63 | 0.610 |
Why?
|
| Computational Biology | 1 | 2019 | 155 | 0.590 |
Why?
|
| DNA | 5 | 2008 | 374 | 0.560 |
Why?
|
| Proteins | 1 | 2019 | 252 | 0.550 |
Why?
|
| gamma-Glutamyltransferase | 2 | 2015 | 18 | 0.540 |
Why?
|
| Scattering, Small Angle | 2 | 2024 | 5 | 0.520 |
Why?
|
| Catalytic Domain | 3 | 2015 | 79 | 0.510 |
Why?
|
| Inverted Repeat Sequences | 1 | 2016 | 2 | 0.510 |
Why?
|
| Base Sequence | 8 | 2023 | 585 | 0.490 |
Why?
|
| Glutamic Acid | 2 | 2015 | 51 | 0.450 |
Why?
|
| Trypanosoma brucei brucei | 4 | 2019 | 6 | 0.430 |
Why?
|
| Lung Neoplasms | 4 | 2021 | 356 | 0.420 |
Why?
|
| Protein Conformation | 7 | 2019 | 257 | 0.420 |
Why?
|
| Protozoan Proteins | 5 | 2018 | 52 | 0.410 |
Why?
|
| RNA, Messenger | 6 | 2023 | 658 | 0.390 |
Why?
|
| Neuraminidase | 1 | 2012 | 3 | 0.390 |
Why?
|
| Benzoic Acid | 1 | 2012 | 6 | 0.390 |
Why?
|
| Poly U | 1 | 2011 | 1 | 0.370 |
Why?
|
| RNA Precursors | 1 | 2011 | 9 | 0.370 |
Why?
|
| Influenza A virus | 1 | 2012 | 33 | 0.370 |
Why?
|
| RNA, Guide | 3 | 2016 | 15 | 0.350 |
Why?
|
| Mutation | 6 | 2020 | 849 | 0.330 |
Why?
|
| Hydrogen Bonding | 6 | 2009 | 39 | 0.320 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2021 | 105 | 0.320 |
Why?
|
| Protein Binding | 4 | 2021 | 657 | 0.300 |
Why?
|
| Amino Acids | 1 | 2009 | 84 | 0.300 |
Why?
|
| RNA Helicases | 2 | 2019 | 8 | 0.280 |
Why?
|
| Binding Sites | 5 | 2019 | 354 | 0.260 |
Why?
|
| Crystallization | 5 | 2008 | 50 | 0.260 |
Why?
|
| Samarium | 1 | 2006 | 1 | 0.250 |
Why?
|
| Bacteriophage P22 | 1 | 2006 | 1 | 0.250 |
Why?
|
| Iodides | 1 | 2006 | 5 | 0.250 |
Why?
|
| Myotonic Dystrophy | 1 | 2005 | 2 | 0.250 |
Why?
|
| Trinucleotide Repeats | 1 | 2005 | 14 | 0.250 |
Why?
|
| Enzyme Stability | 4 | 2009 | 31 | 0.220 |
Why?
|
| Synchrotrons | 1 | 2024 | 3 | 0.220 |
Why?
|
| Humans | 13 | 2024 | 28167 | 0.210 |
Why?
|
| Thyroid Neoplasms | 2 | 2020 | 39 | 0.200 |
Why?
|
| Temperature | 3 | 2009 | 213 | 0.190 |
Why?
|
| Nicotinic Antagonists | 1 | 2021 | 3 | 0.180 |
Why?
|
| Escherichia coli | 4 | 2009 | 336 | 0.180 |
Why?
|
| Receptor, trkC | 1 | 2021 | 2 | 0.180 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2021 | 22 | 0.180 |
Why?
|
| Serine-Arginine Splicing Factors | 1 | 2020 | 5 | 0.170 |
Why?
|
| Static Electricity | 2 | 2011 | 35 | 0.170 |
Why?
|
| Quinazolines | 1 | 2019 | 32 | 0.160 |
Why?
|
| Mutagenesis, Site-Directed | 3 | 2019 | 132 | 0.160 |
Why?
|
| Piperidines | 1 | 2019 | 48 | 0.150 |
Why?
|
| Exosomes | 1 | 2020 | 91 | 0.150 |
Why?
|
| Ribonucleoproteins | 2 | 2018 | 154 | 0.150 |
Why?
|
| Indoles | 1 | 2019 | 99 | 0.150 |
Why?
|
| Molecular Sequence Data | 3 | 2015 | 1052 | 0.150 |
Why?
|
| Drug Resistance | 1 | 2018 | 42 | 0.150 |
Why?
|
| Protein Structure, Secondary | 3 | 2014 | 131 | 0.140 |
Why?
|
| Pyrazoles | 3 | 2024 | 66 | 0.140 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1997 | 24 | 0.140 |
Why?
|
| Myotonin-Protein Kinase | 2 | 2008 | 2 | 0.140 |
Why?
|
| Antineoplastic Agents | 2 | 2024 | 678 | 0.140 |
Why?
|
| DNA, Z-Form | 1 | 1997 | 2 | 0.130 |
Why?
|
| Reproducibility of Results | 2 | 2020 | 775 | 0.130 |
Why?
|
| MicroRNAs | 1 | 2020 | 299 | 0.130 |
Why?
|
| Smoking Cessation | 1 | 2021 | 408 | 0.120 |
Why?
|
| Uracil | 1 | 2015 | 10 | 0.120 |
Why?
|
| Guanine | 1 | 2015 | 25 | 0.120 |
Why?
|
| Oligonucleotides | 1 | 1995 | 27 | 0.120 |
Why?
|
| Solutions | 1 | 2015 | 31 | 0.120 |
Why?
|
| Statistics as Topic | 1 | 2015 | 79 | 0.110 |
Why?
|
| Kinetoplastida | 1 | 2014 | 1 | 0.110 |
Why?
|
| SKP Cullin F-Box Protein Ligases | 1 | 2014 | 3 | 0.110 |
Why?
|
| Dictyostelium | 1 | 2014 | 6 | 0.110 |
Why?
|
| F-Box Proteins | 1 | 2014 | 10 | 0.110 |
Why?
|
| Recombinant Proteins | 4 | 2019 | 414 | 0.110 |
Why?
|
| bcl-X Protein | 1 | 2014 | 35 | 0.110 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2014 | 37 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2014 | 68 | 0.110 |
Why?
|
| Cell Line, Tumor | 3 | 2024 | 1327 | 0.100 |
Why?
|
| Methionine | 2 | 2003 | 37 | 0.100 |
Why?
|
| Structure-Activity Relationship | 1 | 2013 | 211 | 0.100 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2012 | 35 | 0.100 |
Why?
|
| Peptide Fragments | 2 | 2004 | 202 | 0.090 |
Why?
|
| Polysaccharides | 1 | 2012 | 63 | 0.090 |
Why?
|
| Neoplasms | 1 | 2020 | 818 | 0.090 |
Why?
|
| Substrate Specificity | 1 | 2011 | 151 | 0.090 |
Why?
|
| Antiviral Agents | 1 | 2012 | 112 | 0.090 |
Why?
|
| Amino Acid Substitution | 2 | 2009 | 103 | 0.090 |
Why?
|
| Animals | 5 | 2024 | 10416 | 0.090 |
Why?
|
| Molecular Structure | 2 | 2006 | 243 | 0.090 |
Why?
|
| Mitochondria | 1 | 2014 | 366 | 0.090 |
Why?
|
| Glucose | 1 | 2012 | 203 | 0.090 |
Why?
|
| Apoptosis | 1 | 2014 | 774 | 0.080 |
Why?
|
| Pyridines | 2 | 2021 | 108 | 0.080 |
Why?
|
| Protein Structure, Tertiary | 3 | 2019 | 284 | 0.080 |
Why?
|
| Neutron Diffraction | 1 | 2008 | 2 | 0.080 |
Why?
|
| Base Pairing | 3 | 2016 | 25 | 0.070 |
Why?
|
| Protein Folding | 2 | 2004 | 47 | 0.070 |
Why?
|
| Thermodynamics | 2 | 2004 | 93 | 0.060 |
Why?
|
| Crystallography | 1 | 2005 | 6 | 0.060 |
Why?
|
| 3' Untranslated Regions | 1 | 2005 | 34 | 0.060 |
Why?
|
| Base Composition | 2 | 2014 | 108 | 0.060 |
Why?
|
| Rubidium | 1 | 2004 | 1 | 0.060 |
Why?
|
| Mutagenesis | 1 | 2004 | 46 | 0.060 |
Why?
|
| Ions | 1 | 2004 | 19 | 0.060 |
Why?
|
| Proteolysis | 1 | 2024 | 58 | 0.060 |
Why?
|
| Disulfides | 1 | 2004 | 34 | 0.060 |
Why?
|
| Hydrogen | 1 | 2004 | 56 | 0.060 |
Why?
|
| Chromatography, Gel | 1 | 2024 | 36 | 0.060 |
Why?
|
| Ligands | 1 | 2004 | 176 | 0.050 |
Why?
|
| Mice, Nude | 1 | 2024 | 330 | 0.050 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2024 | 270 | 0.050 |
Why?
|
| Automation | 1 | 2003 | 19 | 0.050 |
Why?
|
| Models, Theoretical | 1 | 2004 | 134 | 0.050 |
Why?
|
| Solvents | 1 | 2003 | 40 | 0.050 |
Why?
|
| Water | 1 | 2003 | 135 | 0.050 |
Why?
|
| Mice | 2 | 2024 | 4655 | 0.050 |
Why?
|
| Amino Acid Sequence | 2 | 2014 | 690 | 0.050 |
Why?
|
| Peptides | 1 | 2004 | 289 | 0.050 |
Why?
|
| Proto-Oncogenes | 1 | 2021 | 15 | 0.050 |
Why?
|
| Algorithms | 1 | 2004 | 433 | 0.050 |
Why?
|
| Ficusin | 1 | 2001 | 1 | 0.050 |
Why?
|
| Cross-Linking Reagents | 1 | 2001 | 42 | 0.040 |
Why?
|
| Recombination, Genetic | 1 | 2001 | 61 | 0.040 |
Why?
|
| Nucleotide Motifs | 1 | 2020 | 20 | 0.040 |
Why?
|
| Time Factors | 1 | 2004 | 1593 | 0.040 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2000 | 31 | 0.040 |
Why?
|
| Pyrimidines | 1 | 2020 | 126 | 0.040 |
Why?
|
| Trypanosomiasis, African | 1 | 2019 | 1 | 0.040 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2019 | 46 | 0.040 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2019 | 167 | 0.040 |
Why?
|
| Thymidine | 1 | 1997 | 7 | 0.030 |
Why?
|
| Transcriptome | 1 | 2019 | 214 | 0.030 |
Why?
|
| Deoxyguanosine | 1 | 1997 | 14 | 0.030 |
Why?
|
| Models, Chemical | 1 | 1997 | 90 | 0.030 |
Why?
|
| Deoxycytidine | 1 | 1997 | 66 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2020 | 633 | 0.030 |
Why?
|
| Trypanosomiasis, Bovine | 1 | 2016 | 1 | 0.030 |
Why?
|
| Computer Simulation | 1 | 1997 | 230 | 0.030 |
Why?
|
| Apoenzymes | 1 | 2015 | 6 | 0.030 |
Why?
|
| Methylation | 1 | 1995 | 24 | 0.030 |
Why?
|
| Organophosphonates | 1 | 2015 | 6 | 0.030 |
Why?
|
| Aminobutyrates | 1 | 2015 | 4 | 0.030 |
Why?
|
| Molecular Conformation | 1 | 1995 | 67 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2015 | 68 | 0.030 |
Why?
|
| Catalysis | 1 | 2015 | 133 | 0.030 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2015 | 180 | 0.030 |
Why?
|
| Cattle | 1 | 2016 | 389 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2015 | 250 | 0.030 |
Why?
|
| Dimerization | 1 | 2014 | 76 | 0.030 |
Why?
|
| Permeability | 1 | 2014 | 61 | 0.030 |
Why?
|
| Glycosylation | 1 | 2014 | 70 | 0.030 |
Why?
|
| Kinetics | 2 | 2004 | 545 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2014 | 985 | 0.020 |
Why?
|
| Female | 1 | 2024 | 15191 | 0.020 |
Why?
|
| Mutagenesis, Insertional | 1 | 2004 | 38 | 0.010 |
Why?
|
| Virus Replication | 1 | 2004 | 64 | 0.010 |
Why?
|
| Chemistry, Physical | 1 | 2003 | 13 | 0.010 |
Why?
|
| Chemical Phenomena | 1 | 2003 | 22 | 0.010 |
Why?
|
| Selenomethionine | 1 | 2003 | 5 | 0.010 |
Why?
|
| Trioxsalen | 1 | 2001 | 1 | 0.010 |
Why?
|
| Thymine | 1 | 2001 | 3 | 0.010 |
Why?
|
| DNA Adducts | 1 | 2001 | 6 | 0.010 |
Why?
|